Thomas Whitfield, DPM
Podiatrist · Charlotte, NCNPI 1093877326
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 91 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Paratek Pharmaceuticals, Inc. at 33.6% of the total. Reporting peaked in 2023 at $909 and has fallen 58.0% since, to $381 in 2025.
Across 91 payments — averaging $36.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Paratek Pharmaceuticals, Inc.$1K
- Smith+Nephew$569
- Boston Scientific$440
- Melinta Therapeutics, LLC$386
- Amgen$377
- Kowa Pharmaceuticals America, Inc.$184
- plus $260 from 10 others
What the payments were for
- Food & beverage$3,338100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | 38 | $1,121 |
| Smith+Nephew | 14 | $569 |
| Boston Scientific | 8 | $440 |
| Melinta Therapeutics, LLC | 5 | $386 |
| Amgen | 5 | $377 |
| Kowa Pharmaceuticals America, Inc. | 11 | $184 |
| Cook Medical LLC | 1 | $104 |
| GRT US Holding, Inc. | 1 | $25 |
| Organogenesis Inc. | 1 | $25 |
| Bioventus LLC | 1 | $18 |
| Hartmann USA, Inc. | 1 | $18 |
| Kerecis Limited | 1 | $15 |
| AbbVie | 1 | $15 |
| Nevro Corp. | 1 | $14 |
| Johnson & Johnson | 1 | $13 |
| Convatec Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NUZYRA$727
- Kimyrsa$370
- KRYSTEXXA$250
- COLLAGENASE SANTYL$243
- Orbactiv$133
- Vabomere$133
- Baxdela$133
- Santyl$120
- Cook Medical Peripheral Intervention$104
How this compares
$3,338 in reported general payments places this provider in the 65th percentile of 109 podiatrist providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MitigareColchicine | 12 | $3,334 |
| Colchicine | 20 | $1,727 |
| Nystatin | 33 | $601 |
| Terbinafine Hcl | 37 | $336 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 29 | $279 |
| Baclofen | 23 | $163 |
| Cephalexin | 22 | $117 |
| Furosemide | 13 | $48 |
| Prednisone | 14 | $47 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Charlotte
- William WeilyCharlotte$11K
- Richard LindCharlotte$8K
- Nicholas MillerCharlotte$4K
- Kinjal PatelCharlotte$3K
- Jordan MeyersRaleigh$343K
- Christopher GaulandGreenville$56K
- Scott MartinRocky Mount$14K
- Gretchen LawrenceForest City$12K
- Kristin KirbyHuntersville$10K
- Robert PrzynoschWaynesville$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.